Dr. Yuping Zhu 朱玉萍
Chief Physician
Department of Colorectal Surgical Oncology, Zhejiang Cancer Hospital, Hangzhou
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Surgical and comprehensive treatment of colorectal cancer, including laparoscopic surgery, sphincter-preserving techniques for low rectal cancer, and multi-organ resection. Also treats gastrointestinal stromal tumors.
Dr. Zhu is a Chief Physician in Colorectal Surgery with over 15 years of experience. Roles include Dean of the Wenzhou Campus and Master’s Supervisor. Research includes over 10 SCI papers and participation in provincial-level projects. Focuses on individualized chemotherapy based on standardized protocols.
Professional roles
- Member, Youth Committee, Chinese Society of Clinical Oncology (CSCO)
- Member, Youth Committee, Tumor Surgery Branch, China Medical Promotion Association
- Chair, Youth Committee, Minimally Invasive Oncology Professional Committee, Zhejiang Anti-Cancer Association
- Standing Committee Member, Tumor Surgery Branch, Zhejiang Medical Doctor Association
Name order: in Chinese the family name comes first (Zhu Yuping). Papers usually list the name as Yuping Zhu or Zhu Y.
Selected publications
46 papers on PubMed matched by name and affiliation; 12 as first or senior author since 2016. Most recent first- or senior-author papers:
- Zhejiang Da Xue Xue Bao Yi Xue Ban, 2025 (senior author): [PINK1 suppresses colorectal cancer cell growth through epigenetic regulation of histone modifications]. PubMed 41332108
- Oncologist, 2025 (senior author): Illuminating the FGFR fusion landscape in Chinese patients: unveiling novel molecular insights and clinical implications. PubMed 41092072
- Int J Colorectal Dis, 2025 (senior author): Neoadjuvant therapy for resectable colorectal cancer pulmonary oligometastases: a retrospective cohort study. PubMed 40877638
- Biomark Res, 2025 (senior author): Circulating tumor DNA for MRD detection in colorectal cancer: recent advances and clinical implications. PubMed 40551262
- Neoplasma, 2025 (senior author): Elevated expression of HSF1 promotes the progression of colorectal cancer by activating CLDN3 transcription. PubMed 40162508
- J Oncol, 2022 (first author): The lncRNA NEAT1 Inhibits miRNA-216b and Promotes Colorectal Cancer Progression by Indirectly Activating YY1. PubMed 36262350
- Biomolecules, 2022 (first author): Computational Dissection of the Role of Trp305 in the Regulation of the Death-Associated Protein Kinase-Calmodulin Interaction. PubMed 36291604
- Front Endocrinol (Lausanne), 2022 (senior author): Patterns of Lymph Node Metastasis and Optimal Surgical Strategy in Small (≤20 mm) Gastroenteropancreatic Neuroendocrine Tumors. PubMed 35937823
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion